Name: Neurogene Inc. (NGNE) Balance Sheet
Creator: FinSpry

Neurogene Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Neurogene Inc. (NGNE) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	136.59	148.21	82.02	70.54
Short-Term Investments	175.82	48.95	0.00	0.00
Cash & Short-Term Investments	312.41	197.16	82.02	70.54
Accounts Receivable	0.65	0.60	0.99	0.79
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	0.98	1.10	0.63	0.71
Total Current Assets	315.92	200.35	84.72	73.96
Non-Current Assets
Property, Plant & Equipment (Net)	18.49	20.95	24.55	27.53
Other Non-Current Assets	1.31	1.27	0.00	0.00
Total Non-Current Assets	19.81	22.23	24.55	27.53
Total Assets	335.73	222.57	109.27	101.49
Current Liabilities
Accounts Payable	1.34	2.60	0.63	5.63
Short-Term Debt	3.00	0.00	0.00	0.00
Accrued Liabilities	5.05	10.79	1.80	1.33
Other Current Liabilities	0.34	0.74	0.17	0.27
Total Current Liabilities	15.16	22.97	6.65	10.86
Non-Current Liabilities
Long-Term Debt	10.15	13.37	3.99	4.60
Other Non-Current Liabilities	0.05	0.20	0.00	0.00
Total Non-Current Liabilities	10.20	13.58	248.35	182.51
Total Liabilities	25.36	36.55	255.00	193.36
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-262.30	-187.15	-150.84	-95.65
Additional Paid-in Capital	572.67	373.18	5.10	3.77
Shares Outstanding	14.85	12.82	12.82	12.82
Total Stockholders' Equity	310.38	186.02	-145.74	-91.88
Total Liabilities & Equity	335.73	222.57	109.27	101.49